1. Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes.
- Author
-
Xu S, Hu C, Han J, Luo W, Huang L, Jiang Y, Samorodov AV, Wang Y, and Huang J
- Subjects
- Animals, Mice, Male, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 2 genetics, Ventricular Remodeling drug effects, Signal Transduction drug effects, Cells, Cultured, NF-kappa B metabolism, Cyclooctanes pharmacology, Cyclooctanes therapeutic use, Lignans pharmacology, Lignans therapeutic use, Myeloid Differentiation Factor 88 metabolism, Polycyclic Compounds pharmacology, Polycyclic Compounds therapeutic use, Angiotensin II metabolism, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Toll-Like Receptor 4 metabolism, Toll-Like Receptor 4 genetics, Mice, Inbred C57BL
- Abstract
Cardiac tissue remodeling is characterized by altered heart tissue architecture and dysfunction, leading to heart failure. Sustained activation of the renin-angiotensin-aldosterone system (RAAS) greatly promotes the development of myocardial remodeling. Angiotensin II (Ang II), which is the major component of RAAS, can directly lead to cardiac remodeling by inducing an inflammatory response. Schisandrin B (Sch B), the active component extracted from the fruit of Schisandra chinensis (Turcz.) Baill has been shown to exhibit anti-inflammatory activity through its ability to target TLR4 and its adaptor protein, MyD88. In this study, we explored whether Sch B alleviates Ang II-induced myocardial inflammation and remodeling via targeting MyD88. Sch B significantly suppressed Ang II-induced inflammation as well as increased the expression of several genes of tissue remodeling (β-Mhc, Tgfb, Anp, α-Ska) both in vivo and in vitro. These protective effects of Sch B were due to the inhibition of recruitment of MyD88 to TLR2 and TLR4, suppressing the Ang II-induced NF-κB activation and reducing the following inflammatory responses. Moreover, the knockdown of Myd88 in cardiomyocytes abrogated the Ang II-induced increases in the production of inflammatory cytokines and expression of remodeling genes. These findings provide new evidence that the mechanism of Sch B protection was attributed to selective inhibition of MyD88 signaling. This finding could pave the way for novel therapeutic strategies for myocardial inflammatory diseases., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF